Inhibrx Biosciences, Inc.
Inhibrx Biosciences, Inc., a clinical-stage biopharmaceutical company, engages in the development of biologic therapeutics for people with life-threatening conditions. Its therapeutic candidates includes INBRX-109, a tetravalent therapeutic candidate tar…
Biotechnology
US, La Jolla [HQ]
Revenue Breakdowns
Segment Analysis Beta
The financial segments are sourced from the SEC' 10-K statement.Revenue By Top Segments
Inhibrx Biosciences, Inc. can't present it's sankey chart.
Historical Revenue By Segment
Last 3Y, in million USDInhibrx Biosciences, Inc. can't present revenue by segment